Clinical Trials Browser

Phase 1/2 × Gliosarcoma × tandutinib × Clear all

NCT00379080 2017-04-07

Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma

Phase 1/2 Completed

60 enrolled 22 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma